Market Valuation: Edgewise Therapeutics Inc (EWTX)

The price history on the Edgewise Therapeutics (EWTX) chart on the GURU.Markets platform, where the indicator stands at 5.02, confirms the effectiveness of management by an experienced leadership team with transparent shareholder control. The protection of unique drug formulas for rare muscle pathologies and strict FDA regulations create a powerful barrier to entry for competitors. The business relies on medical test results, remaining independent of general economic fluctuations.

EWTX (Edgewise Therapeutics, Inc.) Market Capitalization history from 07/04/2022 to 11/14/2026

Comprehensive metric breakdowns and analytics for Edgewise Corp (EWTX)

- stock price and consensus target price:

Stock Quotes Edgewise Therapeutics, Inc.|EWTX - Consensus Target

- company stock exchange capitalization indicators:

Market Valuation Edgewise Corp|EWTX - Aggregate Business Value

- business book valuation details:

Accounting Value per Share Edgewise Therapeutics|EWTX - Accounting Capitalization|Market Value to Book Value Ratio edgewisetx.com|EWTX - Total Asset Value of Company

- debt obligations and liquidity statistics:

Total Debt to Capital Edgewise Therapeutics|EWTX - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Edgewise Therapeutics|EWTX - Company Aggregate Debts|Debt to Book Capitalization Ratio Edgewise Corp|EWTX - Company Long-Term Loans and Borrowings|Company Short-Term Debt Edgewise Therapeutics|Quick Ratio edgewisetx.com

- net income and valuation multiples indicators:

EWTX - Net Profit|Future Profit Edgewise Therapeutics|EWTX - Company Value to Net Income|Future Price to Earnings Edgewise Pharma|EWTX - Growth-Adjusted P/E Ratio|EV/EBITDA Multiple Edgewise Corp|EWTX - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months Edgewise Therapeutics|EWTX - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months edgewisetx.com|EWTX - Earnings per share increase in current year|Net earnings per share growth forecast for next year Edgewise Therapeutics

- sales and revenue indicators:

EWTX - Company Total Revenue|Company Projected Revenue Edgewise Therapeutics, Inc.|EWTX - Price-to-Revenue Ratio|Price-to-Projected Revenue Ratio Edgewise Corp

Fundamental company analysis:EWTX (Edgewise Therapeutics, Inc.)

Investors must filter through the volatility of Edgewise Therapeutics (EWTX), assessing how the implementation of energy-efficient technologies and sustainable drug synthesis impact business value. By analyzing the issuer's current market capitalization, one can determine the balance between speculative pressure and the company's strategic value, allowing for the calculation of a potential acquisition premium and confirming the fundamental stability of this biotech asset.

Key competitors